Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Federal Trade Commission
Mallinckrodt
Argus Health
Colorcon
Baxter
Moodys
AstraZeneca
Fish and Richardson
UBS

Generated: July 18, 2018

DrugPatentWatch Database Preview

CATAPRES-TTS-2 Drug Profile

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

Which patents cover Catapres-tts-2, and what generic alternatives are available?

Catapres-tts-2 is a drug marketed by Boehringer Ingelheim and is included in one NDA.

The generic ingredient in CATAPRES-TTS-2 is clonidine. There are twenty-two drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the clonidine profile page.
Drug patent expirations by year for CATAPRES-TTS-2
Pharmacology for CATAPRES-TTS-2
Medical Subject Heading (MeSH) Categories for CATAPRES-TTS-2
Synonyms for CATAPRES-TTS-2
(2,6-dichloro-phenyl)-imidazolidin-2-ylidene-amine
(2,6-Dichlorophenyl)imidazolidin-2-ylidene amine
[3H]clonidine
1416-EP2269989A1
1416-EP2272841A1
1416-EP2280010A2
1416-EP2281559A1
1416-EP2295406A1
1416-EP2298764A1
1416-EP2298765A1
1416-EP2298772A1
1416-EP2301936A1
1416-EP2308839A1
1416-EP2308867A2
1416-EP2308870A2
1416-EP2314571A2
1416-EP2314585A1
1H-Imidazol-2-amine, N-(2,6-dichlorophenyl)-4,5-dihydro-
1H-Imidazol-2-amine, N-(2,6-dichlorophenyl)-4,5-dihydro- (9CI)
1H-Imidazol-2-amine, N-(2,6-dichlorophenyl)-4,5-dihydro-, monohydrochloride
1H-Imidazol-2-amine, N-(2,6-dichlorophenyl)-4,5-dihydro-(9CI)
2-((2,6-Dichlorophenyl)imino)imidazolidine
2-(2,6-Dichloroanilino)-1,3-diazacyclopentene-(2)
2-(2,6-Dichloroanilino)-2-imidazoline
2-(2,6-dichlorophenyl-imino)-imidazolidine
2-(2,6-Dichlorophenylamino)-2-imidazoline
2-(2,6-dichlorophenylimino)-imidazolidine
2-(2,6-Dichlorophenylimino)imidazolidine
2-(2',6'-dichlorophenylamino)-2-imidazoline
2-[(2,6-dichlorophenyl)amino]-2-imidazoline
2-[(2,6-dichlorophenyl)imino]-2-imidazoline
2-[(2,6-dichlorophenyl)imino]-imidazolidine
2-[(2,6-Dichlorophenyl)imino]imidazolidine
2-[(2,6-Dichlorophenyl)imino]imidazoline
2-Imidazoline, 2-(2,6-dichloroanilino)-
2-Imidazoline, 2-(2,6-dichloroanilino)- (7CI,8CI)
2-Imidazoline, 2-(2,6-dichloroanilino)-(7CI,8CI)
2-IMIDAZOLINE, 2-(2,6-DICHLOROPHENYLAMINO)-
2,6-dichloro-N-(2-imidazolidinylidene)aniline
2,6-dichloro-N-2-imidazolidinylidenebenzenamide
2,6-Dichloro-N-2-imidazolidinylidenebenzenamine
2,6-dichloro-N-imidazolidin-2-ylideneaniline
3B1-005252
3h-clonidine
4205-90-7
4205-91-8 (mono-hydrochloride)
57066-25-8
734571A
AB00053441_03
AB00514634
AB00514634_09
AB00514634-07
AB00514634-08
AC1L1EI5
AC1Q3K6V
Adesipress
AK297245
AKOS001595470
AKOS015960367
API0002069
BBL025137
BDBM14062
BDBM50016897
Benzenamine, 2,6-dichloro-N-2-imidazolidinylidene-
BIDD:GT0547
Bio1_000470
Bio1_000959
Bio1_001448
Bio2_000308
Bio2_000788
BPBio1_000040
BRD-K98530306-001-02-1
BRD-K98530306-003-05-0
BSPBio_000036
BSPBio_001588
BSPBio_002055
CAS-4205-90-7
CAS-4205-91-8
Catapres (TN)
Catapres- TTS
Catapres-TTS
CATAPRES-TTS-1
CATAPRES-TTS-3
Catapresan
Catapressan
Catarpres
Catarpres-TTS
Catarpres-TTS (TN)
Catarpresan
CCG-204363
CCRIS 7787
CHEBI:3757
CHEBI:46632
CHEMBL134
Chlofazoline
Chlornidinum
Clofenil
Clonidin
Clonidina
Clonidina [INN-Spanish]
clonidine
clonidine (amino form)
clonidine (imino form)
Clonidine (JAN/USAN/INN)
Clonidine (JAN/USP/INN)
Clonidine [USAN:BAN:INN]
Clonidine solution, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material
CLONIDINE, Clonidine hydrochloride
Clonidine(200 mg)
Clonidinhydrochlorid
Clonidinum
Clonidinum [INN-Latin]
Clopheline
CLORPRES
D00281
D02AZT
D03SKR
DB00575
DivK1c_000774
Dixarit
DR000491
DSSTox_CID_2846
DSSTox_GSID_22846
DSSTox_RID_76756
DTXSID6022846
Duraclon
Duraclont
EINECS 224-119-4
FT-0741246
Gemiton
GJSURZIOUXUGAL-UHFFFAOYSA-N
GTPL516
HE342580
Hemiton
HMS1361P10
HMS1791P10
HMS1989P10
HMS2089G11
HMS3402P10
HSDB 3040
IDI1_000774
IDI1_034058
Isoglaucon
Kapvay®
KBio1_000774
KBio2_000308
KBio2_001821
KBio2_002876
KBio2_004389
KBio2_005444
KBio2_006957
KBio3_000615
KBio3_000616
KBio3_001275
KBioGR_000308
KBioGR_001572
KBioSS_000308
KBioSS_001821
Klofelin
Klofenil
L000193
Lopac-C-7897
Lopac0_000268
LS-79606
M 5041T
M-5041T
M199
MCULE-5017779690
MLS006011925
MN3L5RMN02
MolPort-001-779-668
MRF-0000018
N-(2,6-Dichlorophenyl)-4,5-dihydro-1H-imidazol-2-amine
N-(2,6-Dichlorophenyl)-4,5-dihydro-1H-imidazol-2-amine #
N-(2,6-dichlorophenyl)imidazolidin-2-imine
NCGC00015268-01
NCGC00015268-02
NCGC00015268-03
NCGC00015268-04
NCGC00015268-05
NCGC00015268-06
NCGC00015268-07
NCGC00015268-08
NCGC00024734-01
NCGC00024734-02
NCGC00024734-03
NCGC00024734-04
NCGC00024734-05
NCGC00179680-01
NCGC00179680-02
NCGC00179680-03
NCGC00179680-05
Nexiclon XR
NINDS_000774
Prestwick0_000248
Prestwick1_000248
Prestwick2_000248
Prestwick3_000248
SBI-0050256.P004
SC-47255
SCHEMBL5982
SKF 34427
SMR001550184
SPBio_001233
SPBio_002255
Spectrum_001341
Spectrum2_001187
Spectrum3_000358
Spectrum4_000956
Spectrum5_000759
ST 155BS
ST-155-BS
ST-155BS
STL355995
Tenso-Timelets
Tocris-0690
Tox21_110118
Tox21_110118_1
UNII-MN3L5RMN02
ZB015091
ZINC896484

US Patents and Regulatory Information for CATAPRES-TTS-2

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Boehringer Ingelheim CATAPRES-TTS-2 clonidine FILM, EXTENDED RELEASE;TRANSDERMAL 018891-002 Oct 10, 1984 AB RX Yes No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

Expired US Patents for CATAPRES-TTS-2

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Boehringer Ingelheim CATAPRES-TTS-2 clonidine FILM, EXTENDED RELEASE;TRANSDERMAL 018891-002 Oct 10, 1984 ➤ Try a Free Trial ➤ Try a Free Trial
Boehringer Ingelheim CATAPRES-TTS-2 clonidine FILM, EXTENDED RELEASE;TRANSDERMAL 018891-002 Oct 10, 1984 ➤ Try a Free Trial ➤ Try a Free Trial
Boehringer Ingelheim CATAPRES-TTS-2 clonidine FILM, EXTENDED RELEASE;TRANSDERMAL 018891-002 Oct 10, 1984 ➤ Try a Free Trial ➤ Try a Free Trial
Boehringer Ingelheim CATAPRES-TTS-2 clonidine FILM, EXTENDED RELEASE;TRANSDERMAL 018891-002 Oct 10, 1984 ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKinsey
Healthtrust
Chinese Patent Office
Medtronic
Baxter
McKesson
US Department of Justice
Cerilliant
Deloitte

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.